USP7-IN-3, identified by its CAS number 2202738-42-7, is a small molecule inhibitor specifically targeting the ubiquitin-specific protease 7 (USP7), an enzyme involved in various cellular processes, including protein degradation and regulation of signaling pathways. This compound is characterized by its potential therapeutic applications in cancer treatment and other diseases where USP7 plays a critical role in tumorigenesis and cell survival. USP7-IN-3 is typically evaluated for its potency, selectivity, and pharmacokinetic properties, which are crucial for its efficacy as a drug candidate. The compound's structure includes specific functional groups that facilitate its interaction with the active site of USP7, thereby inhibiting its enzymatic activity. Research into USP7-IN-3 also focuses on its safety profile and potential side effects, which are essential considerations in drug development. Overall, USP7-IN-3 represents a promising avenue for therapeutic intervention in diseases associated with dysregulated ubiquitin-proteasome pathways.

USP7-IN-3

2202738-42-7: USP7-IN-3, identified by its CAS number 2202738-42-7, is a small molecule inhibitor specifically targeting the ubiquitin-specific protease 7 (USP7), an enzyme involved in various cellular processes, including protein degradation and regulation of signaling pathways. This compound is characterized by its potential therapeutic applications in cancer treatment and other diseases where USP7 plays a critical role in tumorigenesis and cell survival. USP7-IN-3 is typically evaluated for its potency, selectivity, and pharmacokinetic properties, which are crucial for its efficacy as a drug candidate. The compound's structure includes specific functional groups that facilitate its interaction with the active site of USP7, thereby inhibiting its enzymatic activity. Research into USP7-IN-3 also focuses on its safety profile and potential side effects, which are essential considerations in drug development. Overall, USP7-IN-3 represents a promising avenue for therapeutic intervention in diseases associated with dysregulated ubiquitin-proteasome pathways.

Please enquire for more information about USP7-IN-3 including the price, delivery time and more detailed product information at the technical inquiry form on this page

USP7-IN-3 is a potent and selective allosteric inhibitor of ubiquitin-specific protease 7 (USP7).

CAS 2202738-42-7

USP7-IN-3

USP7-IN-3

Ref: 3D-CND73842

USP7-IN-3

Ref: TM-T13269